BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease

Affiliations

• ¹ Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
• ² Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Pediatric Hematology, Amsterdam, The Netherlands.
• ³ Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands.
• ⁴ Van Creveldkliniek, University Medical Center, University Utrecht, Utrecht, The Netherlands.
• ⁵ Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
• ⁶ Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
• ⁷ Netherlands Hemophilia Society, Leiden, The Netherlands.
• ⁸ Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Amsterdam, The Netherlands.
• ⁹ Department of Pediatric Hematology, Erasmus University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
• ¹⁰ Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
• ¹¹ Jon J van Rood Center for Clinical Transfusion Medicine, Sanquin Research, Leiden, The Netherlands.
• ¹² Department of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
• ¹³ Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.